Visioneering Technologies's quarterly market cap
increased
from Jun. 2023 (A$7.93 Mil) to Dec. 2023 (A$12.82 Mil) but then
declined
from Dec. 2023 (A$12.82 Mil) to Jun. 2024 (A$7.43 Mil).
Visioneering Technologies's annual market cap
declined
from Dec. 2021 (A$20.68 Mil) to Dec. 2022 (A$12.53 Mil) but then
increased
from Dec. 2022 (A$12.53 Mil) to Dec. 2023 (A$12.82 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Visioneering Technologies's Enterprise Value for Today is A$0.35 Mil.
Visioneering Technologies Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Visioneering Technologies's Market Cap
For the Medical Devices subindustry, Visioneering Technologies's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Visioneering Technologies's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Visioneering Technologies's Market Cap distribution charts can be found below:
* The bar in red indicates where Visioneering Technologies's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Visioneering Technologies (ASX:VTI) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Visioneering Technologies Market Cap Related Terms
Thank you for viewing the detailed overview of Visioneering Technologies's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Visioneering Technologies Inc is a medical device company. It designs, manufactures, sells, and distributes its NaturalVue daily disposable multifocal contact lenses for adults with Presbyopia and children with Myopia. The company offers NaturalVue MF contact lenses. Its Multifocal contact lens provides Presbyopia patients with near, intermediate, and distance vision, making it much easier for eye care professionals to fit their patients. It has two reportable segments; North America which includes its operations in the United States and Canada; and Europe/Asia Pacific which includes its operations outside North America.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ASX:VTI has been successfully added to your 